Open-label Clinical Trial Evaluating an Emollient With Lactobacillus Reuteri for the Treatment of Pediatric Atopic Dermatitis
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this study is to evaluate the efficacy of the emollient topical formulation containing Lactobacillus reuteri in improving atopic dermatitis symptoms in children.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Maximum Age: 12
Healthy Volunteers: f
View:
• Pediatric patients of both sexes, aged between 6 months and 12 years, with a confirmed diagnosis of AD based on Hanifin and Rajka criteria (ANNEX VIII).
• SCORAD index between 20 and 50, inclusive.
• Signed informed consent by parents or legal guardians.
Locations
Other Locations
Spain
Belaneve Clinics
RECRUITING
Alicante
Centro Dermatológico Estético Alicante
RECRUITING
Alicante
Contact Information
Primary
Sofia Nordh, PhD
son@biogaianewsciences.com
+46 8 555 293 00
Time Frame
Start Date: 2025-11-17
Estimated Completion Date: 2026-05
Participants
Target number of participants: 40
Treatments
Experimental: Probiotic Ointment
Twice-daily application for 8 weeks of an emollient topical formulation containing Lactobacillus reuteri
Related Therapeutic Areas
Sponsors
Collaborators: Bioithas SL
Leads: Biogaia New Sciences AB